Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Exploring the Different COVID Tests

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from HealthFirst on MarketScale.

Share

On this episode of HealthFirst Talks, host Grace Huang welcomes two medical expert guests to discuss the different COVID-19 tests, their efficacy, and what test to use in different scenarios. Those guests are Dr. Scott Cohen, Chief Medical Information Officer and Chief Performance Improvement Officer for Bassett Healthcare Network, and Dr. Fiona Collins, dentist and international speaker and author.

Drs. Cohen and Collins explained the two types of COVID-19 tests: PCR tests and antigen tests. “There are two broad types of COVID-19 diagnostic tests. The antigen test takes the nasal fluid and looks for the presence of the antigen. If so, it’s positive. The PCR is looking for the presence of coronavirus RNA,” Dr. Cohen said.

Which is more accurate? Dr. Collins explained, “When looking at accuracy, diagnostic tests can be high sensitivity or high specificity. With high sensitivity, you have very few false negatives. With high specificity, very few false positives.”

The doctors agreed that false negatives were more concerning for COVID-19. With a false positive, the worst that could happen is isolation. A false negative could lead to spread.

When looking at the two tests, Dr. Collins shared, “PCR tests have high specificity and sensitivity. Antigen is only high specificity. It can have a false-negative rate of 15-20%.”

With this in mind, PCR testing is clearly the stronger test, but it may not always be the best choice. For post-exposure testing, Collins said, “PCR is more reliable, but it will take a few days to get back, so patients should quarantine until results.”

In the case of mass testing, the antigen test may be better because it acts as a monitoring system, and people are being tested regularly. “Antigen testing is fastest and least expensive. No lab is needed. Because you’re regular testing, you can overcome the sensitivity issue,” Dr. Cohen added.

Learn more about COVID testing and precautions to take by watching the conversation.

HealthFirst

Part of this channel

HealthFirst

Practice-ready solutions for dental and medical offices nationwide.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Digital health's July 2026 signal: AI wearables, a new CMS office, and the telehealth billing fight

Digital health's July 2026 signal: AI wearables, a new CMS office, and the telehealth billing fight

In mid-2026, digital health is evolving with significant advancements such as AI-driven wearables and innovations in healthcare billing processes involving telehealth. A notable cardiac patch boasting 99.6% accuracy highlights progress in wearable technology. Meanwhile, the establishment of a new CMS AI office demonstrates the growing institutional interest in integrating AI into healthcare operations.

  • 01AI wearables are being developed with high accuracy in health monitoring.
  • 02The establishment of a CMS AI office indicates increased government focus on AI in healthcare.
  • 03Debates over telehealth billing practices continue to shape the healthcare landscape.

Jul 5, 2026

OpenLoop acquires AI communication platform Hey Revia as digital health M&A heats up

OpenLoop acquires AI communication platform Hey Revia as digital health M&A heats up

OpenLoop has acquired AI communication platform Hey Revia as part of growing M&A activity in the digital health sector. The acquisition reflects an ongoing trend in digital health mergers and partnerships, including the announcement of FDA breakthrough status for Aurenar and Sharecare's collaboration with AWS. These developments highlight the increasing investment and strategic alliances shaping the digital health landscape.

  • 01OpenLoop acquires AI communication platform Hey Revia.
  • 02FDA grants Aurenar breakthrough status.
  • 03Sharecare partners with AWS to enhance digital health solutions.

Jul 4, 2026

Healthcare AI governance, data quality, and interoperability top industry agenda in mid-2026

Healthcare AI governance, data quality, and interoperability top industry agenda in mid-2026

The article discusses the challenges faced by healthcare IT leaders in terms of AI governance, data quality, and interoperability by mid-2026. A significant effort is being made to address data readiness challenges and to enhance health data exchange through a $1.3 million federal initiative. These topics are at the forefront of the industry's agenda to improve healthcare infrastructure and outcomes.

  • 01AI governance gaps are challenging healthcare IT leaders.
  • 02Data readiness is a critical concern in healthcare.
  • 03Federal funding is supporting health data exchange initiatives.

Jul 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub